mistletoe-therapy.org
DE
EN
ES
Start
Scientific information
Clinical evidence
Case reports
Case reports on different tumour entities
We present case reports on the following tumour entities:
Skin tumours
Hepatocellular cancer
Colorectal cancer
Head and neck tumours
Liposarcoma
Lymphomas
Breast cancer
Gastric cancer
Neuroblastoma
Neuroendocrine tumours
Renal cell cancer
Oral cancer
Ovarian cancer
Pancreatic cancer
Pleural mesothelioma
Cervix cancer
×
News
Information for patients
Use of mistletoe preparations
Under the skin
Into the vein
Into the tumour
In body cavities
Mistletoe for children
Storage
Mistletoe therapy and other treatments
Effects and efficacy
Immunomodulation
Quality of life
Fatigue syndrome
Side effects
Contraindications
Various types of cancer
Breast cancer
Ovarian cancer
Corpus uteri cancer
Cervical cancer
Gastric cancer
Colorectal cancer
Hepatocellular cancer
Pancreatic cancer
Lung cancer
Bladder cancer
Black skin cancer
Bone cancer
Lymphoma
Preparations
Constituents
abnobaVISCUM®
Helixor®
Iscador®
Iscucin®
Reimbursement
Frequent asked questions
Interesting facts about mistletoe
Scientific information
Safety
Mistletoe in combination with other medicinal products
Chemotherapy
Antihormonal therapy
Antibody therapy
Immune checkpoint inhibitors
Quality of life
Clinical evidence
Meta-analyses and systematic reviews
Clinical studies
Breast cancer
Ovarian cancer
Endometrial cancer
Cervical cancer
Gastric cancer
Colorectal cancer
Hepatocellular cancer
Pancreatic cancer
Lung cancer
Bladder cancer
Skin cancer
Osteosarcoma
Haematological neoplasias
Health services research
Case reports
Skin cancer
Hepatocellular cancer
Rectal cancer
Head and neck tumours
Liposarcoma
Lymphomas
Gastric cancer
Breast cancer
Neuroblastoma
Neuroendocrine tumours
Renal cell cancer
Oral cancer
Ovarian cancer
Pancreatic cancer
Pleural mesothelioma
Cervical cancer
Mistletoe therapy in oncological guidelines
AGO guideline on breast cancer in Germany
SIO guideline on breast cancer, international
Onkopedia guideline, oncological patients Germany
S3 guidelines oncological patients, Germany
Complementary methods in S3 guidelines
S3 guideline complementary medicine in oncology
Constituents and mode of action
Constituents
Immunomodulating properties
Effects on the tumour process
Information for doctors
Scientific literature